Conference | Control strategies for schistosomiasis in Madagascar

21 Oct 2022
Antananarivo, Madagascar

Schistosomiasis is a major public health problem in Madagascar. Chronic long-term consequences of the disease, such as female genital schistosomiasis and liver fibrosis, can lead to high burden disabilities. According to ESPEN, the prevalence is over 50% in most parts of the country and almost 10 million people are in need of chemotherapy. Besides the population targeted through mass drug administration campaigns, there are challenges for the treatment of other populations in need. The population is overall aware of the existence and transmission routes of the disease, nevertheless preventive measures are hard to implement.

In 2023, an orodispensable schistosomiasis treatment for children is expected to be launched on the market. Integration strategies into national policies and guidelines need to be discussed timely in order to favor the smooth and quick integration of the new treatment in the country.

In this first Malagasy conference on schistosomiasis, we want to fuel the discussion between Malagasy stakeholders and policy makers on new strategies that can help control and management of schistosomiasis in the country. International experts will be invited to present the worldwide strategies and work together to identify adapted solutions for the country.

Register now

Please do not hesitate to contact the conference management with any questions - ccsm [at] bnitm [dot] de

Abstract Submissions

General guidelines:

  • The deadline for submission of the abstract is 15.08.2022. Submissions should be made using the registration formular. Submitted abstracts received after the deadline will not be considered.
  • Handing in an abstract will automatically registrate you for the conference. If you decide to not participate, your abstract will be withdrawn.

Guidelines for the authors:

  • All abstracts must be submitted in French or English.
  • All abstracts are limited to 250 words including spaces, excluding the title and author information.
  • Graphs and tables are not accepted.
  • You may include up to 10 co-authors, the presenter will submit the abstract.
  • In your abstract, please formulate clearly and unambiguously the research question, the objective, the methods used and the conclusion of the paper.
  • Use standard abbreviations.
  • Your abstract will not be edited; hence you are responsible for any spelling or grammatical errors.

Abstracts on the following topics, always related to the disease schistosomiasis, can be submitted:

  • Epidemiology
  • Diagnostics
  • Therapeutics
  • Prevention and Control
  • Public health
  • Paediatrics